ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, CIB1, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, UPF1, AQR, FBXO18, DTX3L, NCOA6, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, PNKP, COPS7A, RAD51AP1, TFPT, POLR2B, RAD21, POLR2G, USP51, FANCI, POLQ, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, APEX2, CDC7, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, NPLOC4, UBE2T, POLE2, ERCC5]
GO:0036498;IRE1-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;55.46397693329154;5.825829909099042;0.0018563293936187412;0.6210535250702663;[ERN1, ZBTB17, EXTL2, CTDSP2, EDEM1, LMNA, SYVN1, TPP1, ARFGAP1]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[DDB1, AQR, COPS5, POLR2B, CCNH, EP300, POLR2G, COPS7A, ERCC5, GTF2H4]
GO:0009435;NAD biosynthetic process;11.0;0.7980440201809971;0.8314509624201607;9.500690880982237;2002.0309936558642;5.825829909099042;0.06700617564674446;0.730362164809784;[HK3, TPI1, ADPGK, BPGM, ALDOA, NADSYN1]
GO:0045765;regulation of angiogenesis;6.0;0.7043150770688792;0.675277851124584;8.817594036275793;44.93985318205118;4.1639455212923995;0.0015040964427611868;0.5360646801923071;[MAP3K3, STARD13, RNH1, ROCK2, SPHK1, ITGB2, CIB1, THBS1, MTDH, C3, SFRP1, IL6, RRAS, SP1, TBXA2R, CTSH, EPHA1, GTF2I, CCR2]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[ERN1, RIPK1, CCL19, MAPK8IP3]
GO:0042133;neurotransmitter metabolic process;4.0;0.6073376606709605;0.5536688303354802;7.790244767629174;28.866383444776623;5.266214121163619;9.661318758382117E-4;0.5193144350603088;[MOXD1, CLN3, ALDH5A1, RORA, ATP7A, COMT, DAGLB, ALDH7A1]
GO:0009313;oligosaccharide catabolic process;5.0;0.6763753087927167;0.6284286662572787;8.458452999841867;68.60352119966694;7.069023426578259;0.0022960981153922187;0.6517511986393402;[MAN2B2, MAN2B1]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, SPHK1, ITGB2, CIB1, NLRC4, NFKB1, RELA, MTDH, RPS6KA4, TRIM14, NLRP3, RIPK1, KRAS, TRIM32]
GO:0048243;norepinephrine secretion;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;125.8828662161789;9.777073627680469;0.004213186245031143;0.875;[NISCH]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[ERN1, KARS, PDE6H, TAOK2, RIPK1, CCL19, THBS1, MAPK8IP3]
GO:0000186;activation of MAPKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;5.845247994956144;0.12404468480698592;0.7614812190615239;[MAP3K3, TAOK2]
GO:0030705;cytoskeleton-dependent intracellular transport;5.0;0.5960880403619941;0.5882850320419173;7.885554947433499;33.20429938101479;4.695669262696007;0.0011113180183532213;0.5303777563261461;[IFT122, TRAK1, FNBP1L, DYNLL2, RAB21, FXR1, AP3M1, ARHGAP21, TUBA1C, CLN3, TUBA1B, RHOT2, SPAST, RHOT1, KIF13B, RAB6A, TNPO1, SPG11, CLUAP1, PAFAH1B1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[CRTC2, NCF1, MAML1, CCNH, GFI1, CD80, ARID4A, RORA, IKZF1, GPATCH3, IKZF2, ELK1, YY1, RPS6KA4, ZXDC, DPF2, TRIM24, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, ILF3, SFRP1, KARS, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, RAD21, HLTF, DVL3, SCAP, NLRP3, RIPK1, TFAP2A, ZBTB17, DR1, CREBBP, PBX3, EIF2AK3, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L3, NFE2L1, CDKN1C, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, AATF, FLCN, NIPBL, LBH, NUP62, ZNF485, SEC13, TBP, KLF13, PEG3, DTX3L, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, CREB3, GAL, TFDP2, ELF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, TP53INP2, TP53INP1, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, NFYC, ATAD2, ARID3B, GRHL1, USF2, CD4, NFIB, TNIP2, NFIC, CAMK4, MARS, PSMC1, TAF7, CAMK1]
GO:0030263;apoptotic chromosome condensation;8.0;1.0;0.875;9.628524252492122;25.04782972205294;8.16763571524637;8.383283192138855E-4;0.7926932703116032;[ACIN1]
GO:0001829;trophectodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;7.212124270218933;7.050676185779127E-4;0.6188283705770736;[SP3, CNOT3, BYSL]
GO:0030148;sphingolipid biosynthetic process;7.0;0.6913464685778243;0.6965925995461126;8.992535485772125;238.8284648682076;5.288437257948329;0.007993373787475071;0.6213702925661609;[UGT8, SGPL1, ELOVL5, SPHK2, SPHK1, DEGS1, ELOVL6, SGPP2, CSNK1G2]
GO:0051403;stress-activated MAPK cascade;10.0;0.811012628672052;0.8207473261969463;9.451593544333043;288.8226961090722;5.500407508664414;0.009666635715219814;0.696532107649126;[TNIP2, TAOK2, CCM2, NFKB1]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[CRTC2, RPL3, DGKD, NDUFA11, NCF1, CCNH, NDUFA10, GMNN, PKD2L1, IKZF1, TMEM141, IPO4, GLS, PSMD8, PSMD4, TFG, ZNF207, EP300, OIP5, FBXO5, TLE4, COG4, PRKAB1, KCTD5, MED6, COX7A2L, TBC1D20, KCTD10, PRPF3, SNRPG, KCTD14, CHMP4B, CD2BP2, TSPYL6, PPID, HIST1H2BC, NDUFB10, TUBGCP2, YTHDC1, EPB41, MAX, KLHL12, ATXN2, CCNB1, SPAST, RNF213, TSPAN4, NLRP3, NCKAP1L, RIPK1, ECT2, TRAPPC2, VASP, TRAPPC3, CREBBP, CPSF6, TOR1A, H3F3A, EIF2AK3, NUP153, PILRB, RPL3L, SETX, VIL1, COL1A2, SYNJ1, ARPC2, AHCTF1, GPAA1, SRP54, CLTA, USP39, CLYBL, PPP6C, CHAF1B, CHAF1A, C1QBP, NUP62, TMED2, SNAP29, RBM5, ATPAF2, FGA, SEC13, PDCD6IP, TBP, KCND1, FCER1G, ATPIF1, FGG, CKAP5, TAPBP, DDB1, ALDH5A1, RAD51C, NDUFS7, TRAPPC6B, NDUFS6, POLR1E, VAMP4, CHMP6, ALDOA, SLU7, ITGB3BP, MCM2, COLEC12, NDUFB7, HIST1H2BO, HIST1H2BJ, HDAC1, DDX23, NLRC4, HSD17B8, TM9SF4, NAPG, HLA-DMA, RXRA, HLA-DMB, RBBP5, CCL5, UBN1, AP2S1, STX5, BID, POLQ, RRM1, NDUFA7, NUBPL, RPL23A, GTF2H4, CENPE, CENPF, MARCKS, RAD51, IMPDH2, TAF7, CCDC65, ERCC5, CENPP, SEC24C]
GO:0006295;nucleotide-excision repair, DNA incision, 3'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;8.390779266560578;0.0038535917232456105;0.8041048419030481;[ERCC5]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[DDB1, ERCC5, GTF2H4]
GO:0006293;nucleotide-excision repair, preincision complex stabilization;7.0;1.0;0.8509193652572005;9.628524252492122;108.6814430544141;6.7325511899570465;0.003637470092082656;0.6952223462072524;[DDB1, ERCC5, GTF2H4]
GO:0015680;intracellular copper ion transport;9.0;1.0;0.896240625180289;9.628524252492122;54.57636043096932;8.67846133901236;0.001826621668089006;0.8400575416471059;[CCS]
GO:0006294;nucleotide-excision repair, preincision complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;65.90281547005735;6.409777797693995;0.002205707925099542;0.6787156999164222;[DDB1, CCNH, ERCC5, GTF2H4]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[RAB3B, NCKAP1, CDKN1A, ROCK2, RASGRP2, RAB21, RAB43, RAP1B, RHOT2, RHOT1, RAB20, RRAS, ARHGDIB, CFL1, RAB28, RAB6A, RAB8B, KSR1, SETDB1, RAB27B, RAB11A, NISCH, COL1A2, ALS2, RAB13, RAB18, ELMO1, TAX1BP3, KRAS, ARHGEF1, KPNB1]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[RHOT2, RHOT1, COL1A2, ROCK2, ARHGDIB, CFL1, TAX1BP3, ARHGEF1]
GO:0042147;retrograde transport, endosome to Golgi;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;84.48667651462847;5.311165509025885;0.0028276930298722367;0.5947335637161829;[TMEM87A, GOSR1, VPS52, STX5, VPS54, VPS26B, RAB6A, PLEKHJ1]
GO:0006612;protein targeting to membrane;10.0;0.811012628672052;0.8207473261969463;9.414950152194063;149.73401455281405;4.753193106834193;0.0050114627152184205;0.6583195283905053;[PEX16, TRAM1, RPS9, PEX19, RPL3, NCF1, SSR2, RAB3IP, ZDHHC23, SRP54, ZDHHC24, ZDHHC6, RPL23A, TAOK2, CHMP4B, RAB8B, RPL19]
GO:0045657;positive regulation of monocyte differentiation;9.0;1.0;0.896240625180289;9.628524252492122;840.3783565179247;7.57984905034425;0.02812670730123667;0.7838744581139225;[CD4, ACIN1]
GO:0006605;protein targeting;9.0;0.7192862368539868;0.7558837436072825;9.182237149863703;93.4429707305496;4.015022244900292;0.0031274521371376313;0.6015690495021188;[TRAM1, RPL3, NCF1, ZDHHC23, SRP54, HSD17B4, ZDHHC24, ZDHHC6, TRAK1, AP3M1, LAMP2, KIF13B, LONP2, BID, RAB8B, RPL19, PEX16, TIMM8B, GSTK1, RPS9, PEX19, PMM1, SSR2, RAB3IP, RPL23A, TIMM44, SPCS2, PAN3, ACOX2, VPS41, AGPS, TAOK2, CHMP4B, SLC27A2, ACOT4]
GO:0098506;polynucleotide 3' dephosphorylation;7.0;1.0;0.8509193652572005;9.628524252492122;138.26344778032524;9.777073627680469;0.0046275531681831;0.8509193652572005;[PNKP]
GO:0032793;positive regulation of CREB transcription factor activity;12.0;1.0;0.9481203125901445;9.628524252492122;279.4401483168805;7.004484905440688;0.009352610284359957;0.8063299963962409;[RPS6KA4, CRTC2, LRP8]
GO:0098504;DNA 3' dephosphorylation involved in DNA repair;9.0;1.0;0.896240625180289;9.628524252492122;287.9987222070764;9.777073627680469;0.009639058050248383;0.896240625180289;[PNKP]
GO:0010668;ectodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.390779266560578;7.050676185779127E-4;0.6791048419030481;[VPS52]
GO:0035023;regulation of Rho protein signal transduction;9.0;0.8436909121759173;0.8180860812682478;9.318369324188282;48.758993290020136;4.879233827729558;0.0016319196251719597;0.645764870037956;[BCR, PDGFRB, ABR, FLCN, AKAP13, ALS2, ARHGDIB, GPR55, ARHGEF1, ECT2, ARHGEF5, VAV1]
GO:0000718;nucleotide-excision repair, DNA damage removal;8.0;1.0;0.875;9.628524252492122;149.0421272461911;9.777073627680469;0.0049883058697239;0.875;[PNKP]
GO:0006384;transcription initiation from RNA polymerase III promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;7.9853141584524145;0.015969835568764485;0.8046099625986299;[GTF3C1]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[POLB, POLQ, POLE2, PNKP, CDK2AP1, WRNIP1, BAZ1A]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[HSD3B7, ACLY, STARD3, RXRA, SNX17, SCAP, ERLIN2, APOL1, SCARF1, NFE2L1]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[CDKN1C, BTG2, CDKN1A, ZWILCH, CCNF, GMNN, BUB1B, GPR132, RPS6KA2, ZNF207, CASP2, EP300, FBXO5, TOPBP1, DACT1, TIPIN, PRKAB1, ERN1, ESPL1, TFDP2, CTDSP2, TIMELESS, PRR11, MAX, THBS1, PPM1G, CCNB1, RAD21, TPR, TP53INP1, TP53BP2, E2F7, E2F8, FANCI, ZBTB17, CDKN2C, INTS3, MAD2L1BP, CNOT10, CDC7, ZWINT, CDK9, CNOT4, CNOT6, CENPF, STAG2, RAD51, FAP, CDK5, CNOT1, CNOT3, TAOK2, CNOT8, EIF4G2, EZH2, MAD2L1]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[OXTR, CAD, ATP7A, USF2]
GO:0150020;basal dendrite arborization;10.0;1.0;0.9152410118609203;9.628524252492122;197.41096074002914;8.67846133901236;0.006607167197638665;0.8590579283277371;[TAOK2]
GO:0008206;bile acid metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;102.42028116817174;6.166155715036245;0.003427914638429987;0.6662568552797195;[HSD3B7, ACOX2, OSBPL2, HSD17B4, SLC27A2, GBA2]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[ITPKB, IL4R, IL23A, CD80, NLRP3, NCKAP1L, CCL19]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[SF3B5, SF3B2, WBP4, EIF4A3, DDX23, DDX42, DDX41, CASC3, USP39, EFTUD2, PABPN1, PCF11, U2AF2, POLR2B, DHX16, SNRPB2, POLR2G, SMNDC1, RBM5, AQR, PRPF38A, GPKOW, BUD31, CPSF3, NONO, CPSF2, TFIP11, LSM5, SRRM1, PSPC1, PRPF3, SNRPG, CD2BP2, SLU7]
GO:0002456;T cell mediated immunity;5.0;0.7586651285174919;0.6695735761196662;9.117698628726131;29.48574010893193;6.250713103064308;9.868611860026806E-4;0.609902770639515;[CTSH, BTN3A2]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[OXTR, IL5RA, RASGRP4, PABPN1, CCL5, CTSH, NCAM1, MBP, RIPK1, PDGFRB, MAP3K3, KSR1, GFRA2, SPTB, NFKB1, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, CCM2, KRAS, CALM1, HBEGF]
GO:0031338;regulation of vesicle fusion;6.0;0.7248374789738407;0.6855390520770648;8.935377071932177;48.20117096329211;5.514393750639154;0.0016132498139038735;0.6051266654433651;[VPS18, TRIM9, RABGAP1, VPS41, VPS11, TBC1D8, RUNDC1, TBC1D2B, EVI5L, TBC1D22A, CORO1A, VPS16]
GO:0031339;negative regulation of vesicle fusion;7.0;0.8436909121759173;0.7727648213451592;9.392135474427892;149.70009243093662;7.9853141584524145;0.00501032737232711;0.7592887026755414;[TRIM9, CORO1A]
GO:0034968;histone lysine methylation;10.0;0.7140352122741334;0.772258617997987;9.271849308553389;765.8030232470618;5.528578385631111;0.02563073801010346;0.6979727676072827;[SETD3, SETDB1, RBBP5, ARID4A, RLF, EZH2]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[ITPKB, ECT2, ARID1A, RASGRP2]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[CDK5, ATP13A1, CCL5, CACNA2D3, ITPR2, PKD2L1, NMUR1, CCL19, TRPC4AP, CORO1A, BSPRY]
GO:0010638;positive regulation of organelle organization;6.0;0.4793097133439409;0.562775169262115;6.85593553025234;66.93492229097139;3.4123228708285582;0.0022402516115597013;0.49762666289355856;[HRK, USP36, NCKAP1, FEN1, WDR1, CALCOCO2, WIPF2, ARPC1A, BBC3, UBE2L3, RPS6KA4, NPEPPS, NIPBL, NUP62, CFL1, PDGFRB, ACTR2, TMED9, PDCD6IP, ATPIF1, NSMCE2, PLAUR, YWHAZ, SIRT2, SFRP1, ESPL1, TFDP2, MTF2, ANAPC5, PFDN2, LCP1, EPHA1, MAPRE1, ARHGEF5, BECN1, WBP2, ROCK2, PNKP, CLEC16A, IQGAP2, ANAPC11, CCNB1, RAD21, TPR, VPS11, TP53BP2, NCKAP1L, BID, CLASP1, VASP, RNF20, UBE2B, SETDB1, XRCC5, SURF4, CDK9, VIL1, NSFL1C, CNOT6, PAN3, SYNJ1, ARPC2, CDK5, CNOT1, FES, SDC1, RAB3GAP2, RAB3GAP1]
GO:0071158;positive regulation of cell cycle arrest;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;83.12201169572153;5.395046993006588;0.002782018926502022;0.6268223193749;[ZBTB17, BTG2, CDKN1A, CNOT10, CNOT4, CNOT6, CCNB1, TFDP2, FAP, CNOT1, CNOT3, CASP2, EP300, CNOT8, E2F7, E2F8]
GO:0070625;zymogen granule exocytosis;9.0;1.0;0.896240625180289;9.628524252492122;41.64722869068327;9.777073627680469;0.0013938952642047599;0.896240625180289;[SDF4]
GO:0070987;error-free translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.781341354126479;0.025467164394386097;0.7620391240755716;[NPLOC4]
GO:0015786;UDP-glucose transmembrane transport;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;142.06452249237992;9.777073627680469;0.004754771718050423;0.875;[SLC35C2]
GO:2000391;positive regulation of neutrophil extravasation;10.0;1.0;0.9152410118609203;9.628524252492122;703.074040491935;8.16763571524637;0.023531255409708643;0.8329342821725234;[CD99L2]
GO:0050904;diapedesis;6.0;0.8933024483968273;0.7697715367885581;9.510741216835738;29.137022145890857;8.390779266560578;9.751899096054872E-4;0.7522251544931926;[CD99L2]
GO:0008333;endosome to lysosome transport;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;62.67584315854233;5.769740442447999;0.0020977040659196657;0.618185107137305;[VPS18, DTX3L, MGRN1, VPS33A, VPS41, CLEC16A, VPS11, TRAK1, LYST, VPS16]
GO:0005980;glycogen catabolic process;8.0;0.9326813400603323;0.8413406700301662;9.593432932680852;697.8253482490202;7.292166977892469;0.023355586403854624;0.747921758369865;[PYGB]
GO:0006397;mRNA processing;8.0;0.7140352122741334;0.7320176061370667;9.165900730544008;234.3529203123214;3.6745150330669007;0.00784358133891816;0.5629148696734654;[AHCYL1, CCNH, EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, ALKBH5, PCF11, C1QBP, ARL6IP4, DHX16, ZNF326, RBM5, AQR, BUD31, SSU72, TFIP11, THOC2, SRRM1, ERN1, PSPC1, PRPF3, FASTKD5, SNRPG, CD2BP2, SLU7, TRUB2, SF3B5, SF3B2, POLDIP3, WBP4, DDX23, SUPT6H, PABPN1, U2AF2, POLR2B, SNRPB2, POLR2G, SMNDC1, CPSF6, PRPF38A, GPKOW, WTAP, CPSF3, NONO, CPSF2, LSM5, GTF2H4, PAN3, SON, ACIN1]
GO:0000289;nuclear-transcribed mRNA poly(A) tail shortening;10.0;0.9326813400603323;0.8815816818910864;9.603206444507832;717.2549128915896;6.686031174322154;0.0240058764469685;0.7571649570480019;[CNOT4, CNOT6, PAN3, CNOT1, CNOT3, CNOT10, CNOT8]
GO:0000288;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;10.0;1.0;0.9152410118609203;9.628524252492122;717.2549128915896;7.292166977892469;0.0240058764469685;0.7881627702307852;[CNOT4, CNOT1, CNOT3]
GO:0006701;progesterone biosynthetic process;8.0;1.0;0.875;9.628524252492122;536.5186820467202;8.390779266560578;0.017956797452638215;0.8041048419030481;[STARD3]
GO:0001932;regulation of protein phosphorylation;8.0;0.49565848909023646;0.6228292445451182;7.636094087801916;109.02632868365667;2.531418560085934;0.00364901310371649;0.5044568628857964;[ERRFI1, NCF1, CCNH, CD80, CCNF, CIB1, RPS6KA4, ARL6IP5, PDGFRB, FBXO18, FLT3LG, VRK2, MAPK8IP3, CDC25A, ERN1, SFRP1, TWSG1, KARS, CCNE2, IL23A, DDIT4, JTB, ADNP, EPHA1, PKMYT1, STK3, IL22RA2, C3, RAP1B, CCNB1, RRAS, PRDX1, STK38, DVL3, NCKAP1L, RIPK1, ECT2, MARK2, UBE2B, AMBP, XRCC5, EIF2AK3, TNFRSF10A, PILRB, CDK9, IL6, COPS5, CDK5, GNAQ, PKIA, CALM3, CRIPAK, CALM1, CALM2, CCNJL, EZH2, CDKN1C, CDKN1A, ITGB3, ITGB2, KIF14, PTPN22, DUSP14, FLCN, AKAP13, NUP62, DACT1, HAVCR2, FGA, KSR1, SPHK1, FGG, PLAUR, ZFP91, PPP2R5D, OXSR1, SENP2, GFRA2, SIRT2, ITPKB, NCOR1, ALS2, CTDSP2, LCP2, CHMP6, ARHGEF5, PAFAH1B1, HBEGF, HDAC3, ROCK2, LRP8, THBS1, PPP2CA, SNX25, CCL5, CSK, ZNF622, CCL19, TBX1, MAP3K3, CDKN2C, PDE6H, CCL20, GPR55, CENPE, ITCH, CD4, NLRP12, TAOK2, TAF7, CDK2AP1, KRAS, CAMK1]
GO:0030595;leukocyte chemotaxis;6.0;0.6873818243518346;0.6668112247660618;8.768322987269011;62.06300720445581;4.857092701852345;0.002077192998052941;0.5715122592407831;[HSD3B7, FCER1G, CCL20, ITGB2, LYST, CORO1A, VAV1, IL6, CCL5, NCKAP1L, CCL19, ARHGEF5, CCR2]
GO:0001818;negative regulation of cytokine production;5.0;0.5133656128089943;0.5469238182654175;7.031139619277432;44.35819177106142;4.304802954008995;0.0014846287587966433;0.5103888351227501;[ERRFI1, CUEDC2, PPP1R11, OTUD7B, PTPN22, GPATCH3, THBS1, YY1, RPS6KA4, NLRP7, C1QBP, NLRP3, NCKAP1L, CSK, HAVCR2, LAG3, PDCD1LG2, NFKB1, ITCH, NLRP12, TWSG1, IL6, NPLOC4, IL23A, BCL3]
GO:0046939;nucleotide phosphorylation;8.0;0.6729672293956388;0.7114836146978194;8.910684459341805;199.75304005510822;5.6339389012889365;0.006685554484579823;0.6631198974168686;[HK3, TPI1, ADPGK, PNKP, BPGM, ALDOA]
GO:0008380;RNA splicing;8.0;0.7248374789738407;0.7374187394869203;9.182237149863703;117.47952805794706;3.8501476017100584;0.003931934079388465;0.5718967274016261;[SF3B5, SF3B2, WBP4, EIF4A3, DDX23, DDX42, DDX41, CASC3, USP39, SUPT6H, EFTUD2, PPP2CA, PABPN1, PCF11, U2AF2, POLR2B, C1QBP, ARL6IP4, DHX16, SNRPB2, POLR2G, ZNF326, SMNDC1, RBM5, AQR, PRPF38A, GPKOW, WTAP, BUD31, CPSF3, NONO, CPSF2, TFIP11, THOC2, LSM5, SRRM1, ERN1, SON, PSPC1, PRPF3, SNRPG, CD2BP2, ACIN1, SLU7]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[RPS9, YTHDF3, POLDIP3, ITGA2, EIF4A3, THBS1, FXR1, IL6, RXRA, C1QBP, CCL5, BCL3, POLR2G]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[VIL1, DGKD, CAMLG, FES, FAM83A, HBEGF]
GO:0006520;cellular amino acid metabolic process;6.0;0.406884124246779;0.526562374713534;6.526182243879872;77.81072980309767;4.002522082136061;0.0026042551013992716;0.5278094780068945;[BCKDHA, AHCYL1, EGLN2, TARSL2, BCKDHB, CAD, CPOX, CTNS, AARSD1, AGMAT, GLS, CLN3, ALDH5A1, KARS, MTHFD1, PSAT1, RARS, MARS, MTHFD2L, NARS2, ATP7A, SERINC3, ALDH7A1]
GO:0061418;regulation of transcription from RNA polymerase II promoter in response to hypoxia;12.0;0.8933024483968273;0.8947715367885583;9.557065288509976;532.6985892857467;6.311337724880743;0.017828942385788714;0.770882417347765;[CREBBP, EGLN2, EP300, ARNT, HIF1AN, SIRT2]
GO:0006402;mRNA catabolic process;8.0;0.6696747006330769;0.7098373503165385;9.232108979903876;713.3837118806829;4.434739375715658;0.02387631083298817;0.6017927779105702;[HBS1L, SMG1, RPL3, RNH1, EIF4A3, CASC3, SMG5, PPP2CA, POLR2G, EXOSC3, RPL19, UPF2, UPF1, RPS9, CNOT10, RPL23A, LSM5, ERN1, CNOT4, CNOT6, PAN3, XRN1, CNOT1, CNOT3, SKIV2L, ETF1, CNOT8, DCP1A, DCP2]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, AHCYL1, RPL3, NCF1, ZDHHC6, IPO4, RAB43, IPO8, LAMP2, LONP2, ARFIP1, TBC1D22A, VPS18, GSTK1, RPS9, COG3, AP1B1, TBC1D2B, SYTL3, BCR, CHMP4B, SLC27A2, KPNB1, ACOT4, COPB2, COPA, VPS26B, VPS11, RAB6A, VPS16, PMM1, RAB3IP, NUP153, RAB27B, TIMM44, NFKBIA, PAN3, NPLOC4, CDK5, BCL3, ARF3, TRAM1, SRP54, CLTA, AP1G2, AP1G1, NUP62, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TNPO2, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, TBC1D8, ACOX2, AGPS, SLU7, RABGAP1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, LMNA, AP2S1, HEATR3, STX5, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, SYVN1, RPL23A, RAB11A, ARCN1, SPCS2, SNX17, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, SEC24C]
GO:0043666;regulation of phosphoprotein phosphatase activity;9.0;0.7436939687323844;0.7680876095464813;9.328419660041783;158.30216566976694;5.058574756385375;0.005298231022267458;0.6549363734696205;[PDGFRB, PPP1R11, ROCK2, PPP2R5D, NSFL1C, NUAK1, PPME1, PPP1R7, RCAN3, PHACTR2, NCKAP1L, CALM3, CALM1, CALM2]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[SERPINA3, PYGB, SIGLEC9, WDR1, ITGB3, ITGB2, ABCA12, TRIM9, HK3, PSMD7, PSMD2, LAMP2, PHACTR2, CTSH, SDF4, FAM3C, GUSB, SNAP29, FGA, ACTR2, SERPINB1, FCER1G, FGG, PLAUR, COMMD3, RNASE3, TMEM173, UNC13D, SYTL3, SERPINB6, ACLY, EXOC3, VAMP4, DOCK2, ALDOA, VAMP5, SLC27A2, KPNB1, EXOC1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, THBS1, CORO1A, STX11, C3, RAP1B, CCL5, PSMB1, NCKAP1L, A2M, RAB6A, TMEM30A, XRCC5, HSPA6, SURF4, RAB27B, LILRB3, NFKB1, RAB11A, COPS5, SNX19, CDK5, IMPDH2, VPS41, RAB18, CD9, PTX3, MNDA, DEGS1, MAN2B1, CALM1]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ERRFI1, RABGAP1, DOCK8, RASGRP2, RIC8A, ABR, DOCK11, ARHGAP21, RGS1, CCL5, ARHGDIB, DVL3, NCKAP1L, EVI5L, CCL19, ECT2, A2M, TBC1D22A, STARD13, SEC13, CCL20, TBC1D8, TBC1D2B, ARHGAP25, VAV1, ARFGAP1, BCR, DEPDC1B, SFRP1, ALS2, TBC1D20, GNAQ, RUNDC1, RAB3GAP2, PKP4, TAX1BP3, ARHGEF1, DOCK2, EPHA1, ARHGEF5, RAB3GAP1, EZH2, LIMS1]
GO:0006517;protein deglycosylation;7.0;0.7671156992804218;0.7344772148974115;9.326243380619188;247.8243933626011;6.311337724880743;0.008294459418372403;0.6736814700148209;[RNF103, MAN2B2, EDEM1, SYVN1, DERL2, MAN2B1, MAN1B1]
GO:0031954;positive regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;6.481236761676141;0.026061291479152104;0.7466917612613706;[TAOK2, CALM3, CALM1, CALM2]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[VASP, CRTC2, RXRA, ALDH5A1, IMPDH2, ATPIF1, ALDOA, GLS]
GO:2000036;regulation of stem cell population maintenance;4.0;0.7369933605727446;0.6184966802863723;9.040737587590003;23.085677266902636;6.518977089658987;7.726568423625676E-4;0.5833807915285978;[LBH, CNOT1, CNOT3]
GO:0031952;regulation of protein autophosphorylation;9.0;0.8259837884571596;0.8092325194088689;9.510741216835738;111.97076766282173;5.948432231191374;0.003747560826526104;0.7004437261138039;[ERRFI1, NLRP12, TAOK2, CALM3, PPP2R5D, CALM1, CALM2]
GO:0035752;lysosomal lumen pH elevation;12.0;1.0;0.9481203125901445;9.628524252492122;327.4023537161352;9.777073627680469;0.010957862135890544;0.9481203125901445;[CLN3]
GO:0051601;exocyst localization;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;40.77205030767364;7.57984905034425;0.001364603831334836;0.710754145523778;[EXOC3, EXOC1]
GO:0006094;gluconeogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;174.6088252776196;5.926926025970411;0.005844000244301424;0.6540226378555745;[PER2, CRTC2, TPI1, G6PC3, SLC25A10, BPGM, ALDOA]
GO:0032480;negative regulation of type I interferon production;6.0;0.7980440201809971;0.722142322680643;9.186691500213083;65.25422870398782;6.015873511986907;0.002184000309729388;0.6307723637598831;[YY1, ITCH, NPLOC4, GPATCH3, HAVCR2]
GO:0090305;nucleic acid phosphodiester bond hydrolysis;6.0;0.6073376606709605;0.6267891429256247;8.355558576679234;112.24841944109592;4.100319825412187;0.0037568535816745637;0.5328108591460956;[FEN1, DCLRE1C, POP4, PNKP, SMG5, PCF11, EXO1, EXOSC3, DFFA, CPSF6, REXO1, FBXO18, CPSF3, CPSF2, APEX2, RNASE3, GTF2H4, SND1, ERN1, DDB1, CNOT6, PAN3, XRN1, LAS1L, CNOT1, RPP21, ERCC5, CNOT8, DCP1A, DCP2, KPNB1]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[OXTR, AHCYL1, SUCNR1, DGKD, ROCK2, DGKA, DEFB1, IQGAP2, CRHR1, RIC8A, HEBP1, C3, ABR, AKAP13, GPR132, GNG2, GNAT2, RGS1, TBXA2R, ADORA3, CCL5, NPPA, OR56B1, CCL19, ECT2, NTSR1, CCR2, PDGFRB, SPHK2, CCL20, SPHK1, GPR55, TSHR, VAV1, SFRP1, GAL, GNAQ, GNB2, NMUR1, CALM3, ARHGEF1, CALM1, DAGLB, CALM2, ARHGEF5]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[EGLN2, CSNK2A1, ZFAND2A, EDEM1, ATPIF1, RAD23A, SIRT2, DDB1, ITCH, GGA3, PSMC1, VPS11, UBQLN1, STX5, TRIM32, DACT1]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, CSTB, PYGB, PDXK, SIGLEC9, CLEC12A, ITGB2, UBR4, IQGAP2, C3, RAP1B, HK3, PSMD7, PSMD2, PSMB1, LAMP2, CTSH, NCKAP1L, GUSB, RAB6A, SNAP29, ACTR2, SERPINB1, TMEM30A, FCER1G, XRCC5, HSPA6, SURF4, PLAUR, COMMD3, RNASE3, TMEM173, LILRB3, UNC13D, NFKB1, SERPINB6, ACLY, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1, DOCK2, ALDOA, SLC27A2, KPNB1]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD80, EBI3, PDCD1LG2, CORO1A, CD4, IL6, HLA-DMB, IL23A, CCL5, HLA-DPB1, NCKAP1L, CCL19, CCR2, HLA-DPA1, HAVCR2]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[COLEC12, DGKD, CD163L1, TFRC, WIPF2, ITGB3, ITGB2, STON1, CLTA, FNBP1L, RABEPK, LRP8, CORO1A, TM9SF4, CLN3, KIAA1109, AP2S1, APOL1, SCARF1, FCER1G, AMBP, FNBP1, CDC7, UNC13D, MARCH3, RUFY1, GAK, SYNJ1, CDK5, SNX17, CD9, PIK3C3, DOCK2, CSNK1G2, CSNK1G1]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[COLEC12, FCER1G, CD163L1, TFRC, AMBP, ITGB2, CLTA, FNBP1L, RABEPK, LRP8, GAK, CLN3, SYNJ1, SNX17, AP2S1, CD9, APOL1, SCARF1]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[TRAPPC2, TRAPPC3, PPP6C, SEC13, TFG, TBC1D20, TRAPPC6B, TMED2, STX5, KLHL12, SEC24C]
GO:0006896;Golgi to vacuole transport;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;63.41778050327052;7.069023426578259;0.0021225360411474587;0.7124295520356204;[GAK, AP1G1, VPS52, VPS54]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[XRCC5, PNKP]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, COPA, DCTN4, GOSR1, DCTN3, KLHL12, RAB43, SPAST, TFG, TMED2, STX5, TMED1, TMED4, TRAPPC2, TRAPPC3, TMED9, COG4, COG3, COG1, DYNLL2, SPTB, ARFGAP1, ARCN1, TBC1D20, TRAPPC6B, GOLGB1, SEC24C, SEC22C]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[KIF14, RASGRP4, ABR, FLCN, ARHGAP21, AKAP13, RHOT2, RHOT1, PSD4, NUP62, ARHGDIB, ECT2, A2M, PDGFRB, STARD13, GPR55, ARHGAP25, VAV1, BCR, ITPKB, DEPDC1B, ALS2, KRAS, ARHGEF1, ARHGEF5]
GO:0030970;retrograde protein transport, ER to cytosol;10.0;1.0;0.9152410118609203;9.628524252492122;126.6472701115644;7.004484905440688;0.004238770155490853;0.7734506956670166;[NPLOC4, SYVN1, DERL2]
GO:0090309;positive regulation of methylation-dependent chromatin silencing;12.0;1.0;0.9481203125901445;9.628524252492122;1109.1279723986454;8.390779266560578;0.03712151508581291;0.8772251544931927;[SETDB1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, UBE2Z, UBE2L3, TRIM9, NPEPPS, HERC4, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, RNF44, FBXO18, DTX3L, ARRDC1, ZFP91, TRPC4AP, DDB1, KCTD10, MED20, ANAPC5, HIST1H2BC, HIST1H2BO, HIST1H2BJ, CDCA3, MGRN1, RNF38, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, VCPIP1, RNF213, UBD, HLTF, RFFL, RNF20, UBE2I, UBE2B, KLHL25, SYVN1, FBXL15, LNPEP, FBXL16, MARCH3, CNOT4, ITCH, SPSB1, RNF103, UBE2T, TSPAN17, KBTBD2, FBXL3, TRIM32, ASB3]
GO:0035066;positive regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1302.9179711131005;6.444869117505266;0.043607491943109866;0.7620198587159455;[RPS6KA4, WBP2]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[WDR1, EPB41, WIPF2, LST1, ITGB2, CDC7, VRK2, CORO1A, VIL1, MKLN1, CFDP1, FES, TAOK2, ALDOA, CSNK1G2, CSNK1G1]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[RABGAP1, TBC1D8, RUNDC1, TAX1BP3, TBC1D2B, EVI5L, ECT2, EPHA1, TBC1D22A]
GO:0043320;natural killer cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;133.05394577034187;8.16763571524637;0.004453195824156379;0.8139338954918922;[CORO1A, UNC13D]
GO:0045861;negative regulation of proteolysis;8.0;0.612588685250814;0.681294342625407;8.712233520617966;337.1756827485802;3.92774884773361;0.011284966663181396;0.5758652587320976;[SERPINA3, CSTB, CSTA, ITIH2, DERL3, SERPINA10, CLEC16A, DERL2, NLRC4, UBE2Z, THBS1, GLG1, C3, CLN3, NLRP7, LRIG2, RFFL, A2M, SERPINB1, CSNK2A1, AMBP, PLAUR, TNFRSF10A, SERPINB6, VIL1, CDK5]
GO:0045746;negative regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;188.1075192762445;6.193554689224359;0.006295789384399518;0.6676580400938822;[NFKBIA, ARRDC1, HIF1AN]
GO:0045747;positive regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;187.6437959822434;5.926926025970411;0.006280268983073171;0.6540226378555745;[CREBBP, MAML1, SLC35C2, TSPAN17, EP300]
GO:0045744;negative regulation of G-protein coupled receptor protein signaling pathway;7.0;0.6467165523344657;0.6742776414244334;8.623002386890024;189.85671913105512;6.166155715036245;0.006354333529362364;0.6662568552797195;[MGRN1, CCL5]
GO:0046834;lipid phosphorylation;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;69.34085176665127;4.948759890378168;0.0023207759059147553;0.5762001235249539;[PDGFRB, SMG1, DGKD, SPHK2, DGKA, SPHK1, CD80, IMPAD1, PIK3C3, VAV1, HBEGF]
GO:0006621;protein retention in ER lumen;8.0;1.0;0.875;9.628524252492122;48.69704458819814;7.57984905034425;0.0016298462578721894;0.7626338329336335;[GPAA1]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[BTG2, CDKN1A, CNOT10, CNOT4, CNOT6, CCNB1, TFDP2, CNOT1, CNOT3, CASP2, EP300, CNOT8, E2F7, E2F8]
GO:0050770;regulation of axonogenesis;9.0;0.6324783794010864;0.7124798148808322;8.859391164954255;152.1280667645758;4.606589632642318;0.005091589488238978;0.6318218332219429;[RAB21, SEMA6B, OLFM1, CDK5, RUFY3, KIF13B, ADNP, TRAK1, SSH3, MARK2, RAB11A, PAFAH1B1]
GO:0001845;phagolysosome assembly;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;81.92137458931388;8.16763571524637;0.002741834683053802;0.7686126355688037;[CORO1A]
GO:0047497;mitochondrion transport along microtubule;8.0;0.811012628672052;0.780506314336026;9.446202695698167;156.37963208010012;6.832634648514029;0.005233885553189209;0.7244212536750128;[RHOT2, SPAST, RHOT1, TRAK1]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[TUBA1B, RPL3, IMPDH2, CORO1A, MCM2]
GO:0047496;vesicle transport along microtubule;8.0;0.7866048967936545;0.7683024483968273;9.36615998802463;173.0068769504478;6.039404009397101;0.005790384475450878;0.6838554019015759;[AP3M1, CLN3, TRAK1, PAFAH1B1]
GO:0039536;negative regulation of RIG-I signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;832.8511462772416;7.697632086000634;0.027874778348530416;0.7898978880348613;[NPLOC4, C1QBP, GPATCH3]
GO:0032228;regulation of synaptic transmission, GABAergic;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;30.61939422688933;6.311337724880743;0.001024803569108247;0.6736814700148209;[USP46, NISCH, OXTR, KRAS]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[CNOT4, ITCH, RNF213, UBE2B, DTX3L, UBE2T]
GO:0035176;social behavior;3.0;1.0;0.6981203125901445;9.628524252492122;22.58175877758554;5.8067817141283475;7.557911440223213E-4;0.49507939949363344;[TBX1, OXTR, CIC]
GO:0045638;negative regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;279.0827475916144;5.4730085344763;0.00934064840372507;0.6308092762312435;[NFKBIA, ITPKB, SFRP1, KLF13, GPR55, CIB1, LILRB3, C1QC]
GO:0030163;protein catabolic process;5.0;0.6347111282356054;0.607596575978723;8.35223078658656;135.66522553384723;3.7109655375767217;0.004540593007841691;0.48001996203013964;[CCNF, KIF14, CLTA, BUB1B, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, LAMP2, TRIM24, SKP2, CTSE, C18orf25, SEC13, RNF44, FBXO18, RAD23A, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, CLN3, CCNB1, PSMB5, PSMB1, UBQLN1, AP2S1, RIPK1, RFFL, UBE2I, TOR1A, LRRC29, UBE2B, KLHL25, AMBP, EDEM1, SYVN1, FBXL15, LNPEP, ERLIN2, FBXL16, PGA3, PGA5, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, FBXL3, TPP1, MAD2L1]
GO:0007042;lysosomal lumen acidification;13.0;1.0;0.9625549647676366;9.628524252492122;327.690035788587;7.697632086000634;0.01096749059595845;0.8562122276222088;[CLN3]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[NCKAP1, OXTR, DGKD, NCF1, MAML1, WIPF2, CD80, IL5RA, CIB1, PKD2L1, RORA, TIAL1, RPS6KA4, GNAT2, ADORA3, NPPA, CFL1, EP300, TLE4, IFNAR2, SEMA6B, PDGFRB, LAG3, IL4R, CSNK2A1, FLT3LG, HLA-A, HLA-F, RUNX2, BCR, SFRP1, TWSG1, KARS, SLC9A6, CD8B, IL23A, DDIT4, ELMO1, PSME2, EPHA1, CSNK1G2, CSNK1G1, CD151, DIABLO, EBI3, DTX2, KLHL12, APCDD1, ADIPOR2, CORO1A, CRHR1, RASGRP4, IL22RA2, MTDH, RAP1B, SGPL1, BAG3, TSPAN7, TSPAN4, DVL3, NCKAP1L, TSPAN2, RIPK1, MARK2, HLA-DQA1, ATP6V1F, FAM83A, BBS2, EIF2B4, CREBBP, UBE2B, BTN2A1, EIF2AK3, IFT122, TNFRSF10A, PILRB, PILRA, NFKB1, SETX, VIL1, NFKBIA, IL6, COL1A2, ARPC2, PTPRA, FES, GNAQ, SDC1, CALM1, HLA-DRB3, CPEB4, CIITA, CDKN1A, SIGLEC9, ITGB3, ITGB2, ARPC1A, USP34, PTPN22, NUP62, CASP2, CTLA4, CCR2, DACT1, HLA-DPA1, ACTR2, FCER1G, CAMLG, ITGA2, ROM1, PLAUR, PDCD1LG2, BTN3A2, SENP2, GFRA2, YWHAZ, SIRT2, VAV1, DDB1, ITPKB, TAX1BP3, LCP2, LCP1, DAGLB, HBEGF, ROCK2, NOTCH2NL, NEDD9, LILRA2, LRP8, AKAP2, RELA, CLN3, GNG2, POLR2B, CCL5, MKNK2, IL21R, AP2S1, POLR2G, NCAM1, CSK, CCL19, BID, MAP3K3, CCL20, EYA2, G0S2, LILRB3, TSHR, ITCH, CD4, TNIP2, TSPAN17, HLA-DPB1, CD9, CCM2, MNDA, KRAS, LIMS1]
GO:0046726;positive regulation by virus of viral protein levels in host cell;7.0;1.0;0.8509193652572005;9.628524252492122;75.14244873640052;8.390779266560578;0.0025149501353939727;0.7800242071602487;[DDB1, TBC1D20]
GO:0006513;protein monoubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.574457031221845;155.4032479663248;5.649939242635378;0.005201206855589802;0.704179167478338;[DDB1, RNF20, UBE2B, DTX3L, MGRN1, UBE2T, KLHL12]
GO:0045879;negative regulation of smoothened signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;188.1075192762445;6.444869117505266;0.006295789384399518;0.6805102716434839;[MGRN1, RFX4, IFT122, RUNX2]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[USP36, PPP1R11, USP32, CCNF, USP34, KIF14, BUB1B, UBE2Z, UBE2L3, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, USP46, SEC13, RNF44, FBXO18, DTX3L, ARRDC1, RAD23A, TRPC4AP, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, USP41, DERL3, RNF38, USP12, UBR4, DERL2, NEDD8, PSMB10, PSMA7, ANAPC11, ARNTL, CCNB1, RNF213, PSMB5, TP53INP2, UBD, PSMB1, UBQLN1, USP51, RFFL, RNF20, UBE2I, LRRC29, UBE2B, KLHL25, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, FBXL3, TRIM32, MAD2L1]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[OXTR, ATP13A1, GPR55, ITPR2, CLN3, CD4, GNAT2, TBXA2R, CCL5, PDE6B, CALM3, CCL19, CALM1, CALM2, KCNK3, NTSR1, GTF2I, CCR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[ANKRD17, COLEC12, HIST1H2BJ, NCF1, CFH, DEFB1, NLRC4, ZC3HAV1, LILRA2, LYST, CORO1A, RELA, C2, C3, PPP6C, PRDX1, C1QBP, SLAMF7, NLRP3, CSK, APOL1, HAVCR2, FGA, APOBEC3F, FCER1G, DTX3L, APOBEC3H, XRCC5, NONO, WRNIP1, RNASE3, TMEM173, SIRT2, NFKB1, ITCH, POLR3C, IL23A, FES, ELF4, PSPC1, POLR3E, TRIM14, PTX3, SERINC3, TRIM32, CD244, C1QC, HIST1H2BC]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[XRCC5, PNKP]
GO:0031124;mRNA 3'-end processing;9.0;0.8436909121759173;0.8180860812682478;9.52844079393514;355.1646528804444;5.407625775213448;0.011887041304472852;0.6727868588050205;[AHCYL1, CPSF6, POLDIP3, CPSF3, CPSF2, EIF4A3, SSU72, THOC2, CASC3, SRRM1, PABPN1, PCF11, U2AF2, SLU7]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[NFKBIA, RPS6KA4, MAP3K3, TNIP2, NFKB1, RELA]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[NCKAP1, WDR1, EPB41, ROCK2, WIPF2, ARPC1A, CORO1A, ABR, CFL1, NCKAP1L, PDGFRB, PDCD6IP, BCR, VIL1, NISCH, MKLN1, PARVG, CDK5, RAB13, TAOK2, ELMO1, KRAS, DOCK2, TRIM32, ARHGEF5, PAFAH1B1]
GO:0032456;endocytic recycling;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;48.979792040619635;6.409777797693995;0.0016393095606485504;0.6509166472493662;[RAB13, VPS52]
GO:0019932;second-messenger-mediated signaling;6.0;0.6547035408479693;0.6504720830141292;8.316337863525954;26.42836680105094;4.103750360508977;8.845336528452411E-4;0.5329862968704817;[MCTP1, DGKD, KSR1, CCL20, SPHK1, EIF2AK3, ITPR2, DEFB1, CRHR1, TSHR, PPP2CA, AKAP13, GNG2, GAL, TBXA2R, GNAQ, RCAN3, NMUR1, CALM3, CALM1, CALM2, CCR2]
GO:0071108;protein K48-linked deubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;204.99431233642397;6.375876246018314;0.006860975150996652;0.7413036195908642;[VCPIP1, USP34, OTUD7B]
GO:0043988;histone H3-S28 phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;711.4828594708514;8.67846133901236;0.023812691013487215;0.8762458687964789;[RPS6KA4]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[FANCI, TAOK2, TOPBP1]
GO:0006680;glucosylceramide catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;1602.2547523417068;9.083926447120524;0.053626024625218205;0.8797934328124444;[GBA2]
GO:0006681;galactosylceramide metabolic process;9.0;0.8933024483968273;0.8428918493787028;9.537552474286395;334.42747028022615;7.697632086000634;0.011192986465096231;0.7898978880348613;[GALC, UGT8, CLN3, ALDH5A1]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[RAB3B, AHCYL1, SYS1, RPL3, DGKD, TFRC, NCF1, ZDHHC6, IPO4, RAB43, EIF4ENIF1, IPO8, LAMP2, LONP2, ARFIP1, TBC1D22A, VPS18, GSTK1, RPS9, ARRDC1, VPS33A, COG4, VPS33B, COG3, AP1B1, COG1, TBC1D2B, SYTL3, BCR, RUFY1, UNC50, CHMP4B, KIF20A, SLC27A2, KPNB1, ACOT4, PPID, COPB2, COPA, SUCNR1, VPS26B, VPS8, VPS11, NLRP3, ECT2, RAB6A, ATP6V1F, VPS16, BBS2, TOR1A, PMM1, VTA1, RAB3IP, NUP153, RAB27B, TIMM44, NFKBIA, PAN3, NPLOC4, CDK5, BCL3, ARF3, TRAM1, AHCTF1, SFT2D3, SRP54, CLTA, LYST, AP1G2, AP1G1, NUP62, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TNPO2, SNAP29, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, PDCD6IP, DTX3L, SSR2, RHBDF2, FGG, TBC1D8, BTN3A2, SENP2, ARFGAP1, AFTPH, GAL, ACOX2, AGPS, EXOC3, LCP2, CHMP6, SLU7, VAMP5, PAFAH1B1, EXOC1, SEC22C, RABGAP1, GOSR1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, RRBP1, NLRC4, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, SNX25, LMNA, VPS52, AP2S1, HEATR3, STX5, VPS54, CCL19, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, SYVN1, RPL23A, RAB11A, ARCN1, CENPF, SPCS2, MCM3AP, SNX19, SNX17, SNX14, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, APBA3, SEC24C]
GO:0006684;sphingomyelin metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.52844079393514;217.00372642606885;7.212124270218933;0.007262919432806085;0.7197477358342742;[CLN3]
GO:0046579;positive regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;287.86983276338884;5.905872616772578;0.009634744236561129;0.6982672254532021;[PDGFRB, ITPKB, AKAP13, ALS2, GPR55, KRAS, RASGRP4]
GO:1902953;positive regulation of ER to Golgi vesicle-mediated transport;7.0;1.0;0.8509193652572005;9.628524252492122;124.3029356805784;8.67846133901236;0.004160307391849762;0.7947362817240173;[TBC1D20]
GO:0021954;central nervous system neuron development;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;34.232648149996464;6.343086423195323;0.0011457359261972313;0.6146267465268138;[BTG2, CDK5, UQCRQ, GNAQ, ATP7A, GBA2]
GO:0043987;histone H3-S10 phosphorylation;11.0;0.9326813400603323;0.8987696223598284;9.59462270081644;711.4828594708514;7.9853141584524145;0.023812691013487215;0.8407982897480031;[RPS6KA4, CCNB1]
GO:0046339;diacylglycerol metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.387362195675234;85.59385656069774;6.943860283624253;0.0028647493496168257;0.7060287030842711;[DGKD, DGKA, DAGLB]
GO:0051126;negative regulation of actin nucleation;12.0;0.9326813400603323;0.9144609826203107;9.59573442966913;318.2257087533811;7.697632086000634;0.010650728087431447;0.8417775754447168;[CORO1A]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, CREBBP, EGLN2, ITGA2, ITPR2, ARNT, RORA, THBS1, TM9SF4, SIRT2, NPEPPS, ALKBH5, SFRP1, CCNB1, TBL2, NPPA, LMNA, DDIT4, UBQLN1, EP300, SCAP, ATP7A, KCNK3]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[SEMA6B, PPP2CA, FLCN, SERTAD3, SFRP1, CDKN1A, GAL, CDKN2C, CDK5, SERTAD2, NPPA, ADIPOR2]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[C12orf57, ALS2, CDK5, NFIB, TAOK2, NPTX1, PAFAH1B1]
GO:0016255;attachment of GPI anchor to protein;7.0;1.0;0.8509193652572005;9.628524252492122;151.15475272427284;7.9853141584524145;0.005059013543235805;0.7592887026755414;[PIGS, PIGT, GPAA1]
GO:0030301;cholesterol transport;7.0;0.7763722522362496;0.7391054913753253;8.999915593069748;37.84975072563126;5.845247994956144;0.0012667970942227542;0.6498456195510879;[STARD3]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[RAB3B, NCKAP1, OXTR, DGKD, DGKA, CD80, SIRPG, IL5RA, DEFB1, RAB43, RPS6KA4, DOCK11, RPS6KA2, ARHGDIB, CFL1, ARL6IP5, EP300, SNIP1, IFNAR2, PDGFRB, IGFBP5, ERN1, BCR, NISCH, DEPDC1B, KARS, DDIT4, ELMO1, KPNB1, DIABLO, CLEC16A, ITPR2, RASGRP2, KRCC1, CRHR1, RASGRP4, STK3, RAP1B, ABR, NUAK1, CCNB1, RHOT2, RHOT1, ZMAT1, RRAS, TBXA2R, STK38, TP53BP2, DVL3, STK38L, MBP, RIPK1, ECT2, RAB6A, MARK2, SETDB1, EIF2AK3, IFT122, CNOT10, RAB27B, NFKB1, SETX, NFKBIA, CNOT4, CNOT6, IRAK1BP1, COL1A2, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, CNOT3, NMUR1, CALM3, CNOT8, CALM1, CALM2, BTG2, CDKN1A, MCTP1, PRKCSH, MAST3, DOCK8, BBC3, POLB, FLCN, AKAP13, AKAP11, NKIRAS1, C1QBP, CASP2, CTSH, RAB8B, CCR2, KSR1, SPHK1, OXSR1, TMEM173, GFRA2, SPTB, SIRT2, VAV1, ITPKB, GAL, ALS2, TFDP2, TAX1BP3, PIK3C3, LCP2, ARHGEF1, LCP1, DOCK2, ARHGEF5, EXOC1, HBEGF, ROCK2, TANK, RELA, RAB21, PPP2CA, GNG2, RAB20, PABPN1, CCL5, TIFA, MKNK2, NCAM1, ZNF622, RAB28, BID, E2F7, E2F8, MAP3K3, CCL20, TSHR, RAB11A, SNRK, ITCH, TNIP2, CAMK4, RAB13, TAOK2, RAB18, CCM2, KRAS, CAMK1, ASB3]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, CRTC2, DGKD, PKD2L1, NLRC4, CLYBL, GLS, SPAST, RXRA, RNF213, RIPK1, ECT2, BID, VASP, POLQ, PDCD6IP, KCND1, FCER1G, TOR1A, ATPIF1, EIF2AK3, KCTD5, MARCKS, ALDH5A1, RAD51, KCTD10, IMPDH2, KCTD14, CHMP4B, ALDOA]
GO:0032957;inositol trisphosphate metabolic process;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;89.22653499692481;8.390779266560578;0.002986331827679007;0.7800242071602487;[ITPKB]
GO:0032958;inositol phosphate biosynthetic process;7.0;0.8259837884571596;0.7639112594857803;9.488762310116963;271.0835579887486;7.212124270218933;0.009072922726520409;0.7197477358342742;[ITPKB]
GO:0001675;acrosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;135.95286722949908;7.138016298065211;0.004550220116534439;0.6881587980249038;[TBC1D20, PAFAH1B1]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[MTPN, NCKAP1, WDR1, ROCK2, WIPF2, ARPC1A, IQGAP2, CORO1A, AKAP13, ARHGDIB, CFL1, PPFIA1, NCKAP1L, ARFIP1, CLASP1, VASP, PDGFRB, ACTR2, SSH3, SPTB, VIL1, SFRP1, ARPC2, CDK5, FES, TAOK2, EPHA1, ARHGEF5]
GO:0046470;phosphatidylcholine metabolic process;7.0;0.7508913569872202;0.7263650437508107;9.129533086373135;183.95696187605128;5.500407508664414;0.006156873963474197;0.6322104610454062;[PLA2G12A, STARD10, DBI, PNPLA6]
GO:0046475;glycerophospholipid catabolic process;7.0;0.7866048967936545;0.7442218136540277;9.352270875863963;589.1209293346869;6.832634648514029;0.01971734733041741;0.7003406189322132;[PNPLA6]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[MTPN, CDKN1A, KIF14, DERL2, CIB1, TMEM97, RASGRP2, ADIPOR2, FBLN5, RAB21, PPP2CA, FLCN, KIAA1109, SERTAD3, SERTAD2, NPPA, SEMA6B, CDKN2C, EGLN2, CSNK2A1, IGFBP5, SPHK1, H3F3A, RAB11A, OLFM1, ITCH, SFRP1, GAL, CDK5, RUFY3, TAOK2, ADNP, TRIM32, EIF4G2, PAFAH1B1, HBEGF]
GO:2000409;positive regulation of T cell extravasation;11.0;0.8653626801206646;0.8651102923899945;9.5544162803384;762.2132388158234;8.67846133901236;0.02551059115578615;0.8762458687964789;[CD99L2, CCR2]
GO:0042791;5S class rRNA transcription by RNA polymerase III;12.0;1.0;0.9481203125901445;9.628524252492122;1408.966996987758;7.9853141584524145;0.04715685740120772;0.8564896500084854;[GTF3C1]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PDGFRB, CDCA2, PPP1R7, CALM3, PPP2R5D, CALM1, CALM2]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[FGA, CLN3, SPCS2, RHBDF2, FGG, CASP2, CTSH, LONP2, PIK3C3, CTSE, SEC11A]
GO:0033129;positive regulation of histone phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1473.5624568792941;7.697632086000634;0.04931880931163779;0.8088982747154926;[CDK9, RPS6KA4, CCNB1]
GO:1904355;positive regulation of telomere capping;9.0;0.9326813400603323;0.8625812952104552;9.59462270081644;613.4505056642549;6.943860283624253;0.02053163635497091;0.7513499630073597;[PNKP]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, CD80, LST1, SIRPG, CIB1, COMT, FLCN, ADORA3, RPS6KA2, FNTB, NUP62, TRIM24, CTLA4, RBM5, HAVCR2, KLF13, IGFBP5, ATPIF1, EMP3, PDCD1LG2, SIRT2, SFRP1, TWSG1, GAL, KARS, TAX1BP3, BECN1, THBS1, STK3, TP53INP1, LMNA, CSK, E2F7, TFAP2A, ZBTB17, CDKN2C, IDH2, GLMN, IFT122, PER2, ITCH, IL6, FAP, NFIB, CD9, MNDA, CNOT8, TRIM32]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, MAML1, CCNH, GFI1, ARID4A, RORA, IKZF1, IKZF2, ELK1, YY1, RPS6KA4, DPF2, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, RAD21, HLTF, SCAP, NLRP3, RIPK1, TFAP2A, ZBTB17, DR1, CREBBP, PBX3, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, AATF, FLCN, NIPBL, ZNF485, KLF13, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, CREB3, GAL, TFDP2, ELF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIB, TNIP2, NFIC, PSMC1, TAF7, CAMK1]
GO:0043523;regulation of neuron apoptotic process;7.0;0.7043150770688792;0.7030769037916401;8.763526815005518;34.538657273781794;4.5143834387755835;0.0011559777761799947;0.581785144256483;[TFAP2A, BTG2, EGLN2, NONO, KIF14, CORO1A, CLN3, CDK5, CASP2, KRAS, ADNP, SNCB, CPEB4]
GO:0042797;tRNA transcription by RNA polymerase III;12.0;1.0;0.9481203125901445;9.628524252492122;1408.1403184145688;7.9853141584524145;0.04712918921332549;0.8564896500084854;[GTF3C1]
GO:0000432;positive regulation of transcription from RNA polymerase II promoter by glucose;13.0;1.0;0.9625549647676366;9.628524252492122;6356.890744585131;8.67846133901236;0.21275941239102195;0.9063718812344532;[USF2]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[CLN3, BTG2, NONO, KIF14, KRAS, ADNP, SNCB, CORO1A, CPEB4]
GO:0051145;smooth muscle cell differentiation;5.0;0.7763722522362496;0.6784271379790451;8.85533436425864;21.75937296335754;6.7325511899570465;7.282666309192915E-4;0.6345439928109722;[MKL1]
GO:0015809;arginine transport;10.0;0.7980440201809971;0.8142630219514189;9.377209824211215;84.43547984238377;7.8311634786251565;0.00282597952332622;0.8157270763441555;[CLN3]
GO:0072520;seminiferous tubule development;4.0;1.0;0.75;9.628524252492122;49.55861996907746;7.379178354882098;0.0016586824105027187;0.6273715242355574;[WDR48, TBC1D20]
GO:0097345;mitochondrial outer membrane permeabilization;10.0;1.0;0.9152410118609203;9.628524252492122;138.60241592490854;7.697632086000634;0.004638898126930778;0.8088982747154926;[RHOT2, RHOT1, EYA2, BID]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[ATP13A1, CACNA2D3, ITPR2, PKD2L1, CCL19, TRPC4AP]
GO:0072643;interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;7.8311634786251565;0.004587596526932657;0.8157270763441555;[BTN3A2]
GO:0030520;intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;54.01143535742291;6.7325511899570465;0.0018077141342769656;0.719302980950052;[EGLN2, NCOA6, TAF7, SAFB, ARID1A]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[EIF2B4, BTN2A1, PTPN22, BTN3A2, NFKB1, RELA, CD4, HLA-DPB1, LCP2, CSK, HLA-DRB3, HLA-DQA1, HLA-DPA1]
GO:0016236;macroautophagy;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;39.83166466328102;5.244474134527214;0.0013331299701091492;0.5584436629936305;[BECN1, CLN3, GABARAPL1, CALCOCO2, VTA1, UBQLN1, C6orf106, CHMP4B, PIK3C3, CHMP6, DYNLL2, PRKAB1]
GO:0036066;protein O-linked fucosylation;9.0;1.0;0.896240625180289;9.628524252492122;187.13222888987366;7.697632086000634;0.006263147292872048;0.7898978880348613;[SLC35C2]
GO:0006678;glucosylceramide metabolic process;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;253.7483476259492;8.16763571524637;0.008492728836353958;0.8139338954918922;[CLN3, ALDH5A1, GBA2]
GO:0061502;early endosome to recycling endosome transport;6.0;1.0;0.8231203125901445;9.628524252492122;50.18376484494501;9.083926447120524;0.001679605446904144;0.7876727335416686;[CORO1A]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CALM3, CALM1, CALM2, CORO1A, NTSR1]
GO:0097352;autophagosome maturation;5.0;1.0;0.7902410118609202;9.628524252492122;38.04764185170599;6.599019797332524;0.0012734203321220245;0.6277151911823093;[CLN3, GABARAPL1, SNX14, VPS33A, LAMP2, UBQLN1, SNAP29, VPS16]
GO:0071421;manganese ion transmembrane transport;9.0;0.8933024483968273;0.8428918493787028;9.4949928598676;98.82364420707664;8.390779266560578;0.003307538436105251;0.8253454670833372;[ATP13A1]
GO:0031047;gene silencing by RNA;8.0;0.7671156992804218;0.7585578496402109;9.168991923113682;70.59795582467933;5.885253329569843;0.002362850047416754;0.6759721289664703;[CNOT6, CNOT1, CNOT3, CNOT10, CNOT8, SND1]
GO:0018401;peptidyl-proline hydroxylation to 4-hydroxy-L-proline;10.0;1.0;0.9152410118609203;9.628524252492122;440.6873543070796;7.697632086000634;0.014749409155788068;0.8088982747154926;[EGLN2]
GO:0016601;Rac protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;6.7325511899570465;9.9090025448413E-4;0.719302980950052;[NISCH, NCKAP1, ALS2, ELMO1]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[ONECUT2, ELL, CCNH, INTS10, ARID4A, HOXC13, ELK1, AFF4, TRIM24, ZNF768, EP300, IER2, GTF2I, TBP, KLF13, MKL1, ARNT, CREB3, NCOR1, TFDP2, ELF4, RFX4, TFEC, MED20, LCOR, WBP2, MAX, RPAP1, SUPT6H, GTF2E2, RELA, ARNTL, POLR2B, RAD21, TAF1A, HLTF, HIVEP1, POLR2G, HIVEP2, TFAP2A, POLR2J3, ZBTB17, NFYC, INTS3, PBX3, ARID3B, DEK, GRHL1, USF2, GTF2H4, FLI1, NFKB1, CDK9, GFI1B, STAG1, TFCP2, COPS5, SP1, NFIB, NFIC, MAFF, NFE2L3, INTS4, TAF7, NFE2L1]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[PDGFRB, MAP3K3, SMG1, CAD, EIF2AK3, VRK2, CLK4, CLK3, CLK1, ERN1, BCR, CDK5, FES, CAMK4, MKNK2, TAOK2, TRIM24, RIPK1, CSK, EPHA1, MARK2, CSNK1G2]
GO:0006487;protein N-linked glycosylation;8.0;0.7980440201809971;0.7740220100904985;9.34084218004034;176.5615275388073;5.500407508664414;0.005909355431665436;0.6562910957882058;[PMM1, DERL3, MGAT4B, SYVN1]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[BBS2, PER2, NIPBL, TBL1XR1, FAM120B, EP300, SDF4, SOX8, OSBPL11, SENP2, TRIM32]
GO:0006006;glucose metabolic process;6.0;0.7090535922965819;0.6776471087384355;8.572471578242808;34.676020684410545;5.040875179285974;0.0011605752059146955;0.5809109036834981;[PER2, NISCH, HK3, CRTC2, TPI1, G6PC3, ALDH5A1, IGFBP5, ADPGK, SLC25A10, BPGM, ALDOA]
GO:0008306;associative learning;7.0;0.8436909121759173;0.7727648213451592;9.223059144383958;22.449675191779697;5.459585514144159;7.513704252729093E-4;0.6301228223472235;[RIC8A, ACTR2, CLN3, BTG2, CDK5, EIF4A3, CTNS, KRAS]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[NCKAP1L, CORO1A]
GO:0010735;positive regulation of transcription via serum response element binding;12.0;1.0;0.9481203125901445;9.628524252492122;1467.8987330058965;8.390779266560578;0.04912924957061573;0.8772251544931927;[MKL1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[TLE4, CSNK2A1, UBE2B, USP34, KLHL12, SENP2, APCDD1, DDB1, SFRP1, GNG2, GNAT2, AP2S1, DVL3, SDC1, TAX1BP3, CALM1, MARK2, CSNK1G2, DACT1, CSNK1G1]
GO:0030100;regulation of endocytosis;6.0;0.5902001590945054;0.6182203921373972;8.152617732682543;44.90533409728707;4.321752512322768;0.0015029411200592913;0.5441349370523758;[CD151, MCTP1, SIRPG, STON1, C2, RAB21, C3, ABR, ATXN2, RAB20, AP2S1, NCKAP1L, CSK, CCL19, SH3GL1, FCER1G, TOR1A, ITGA2, ARFGAP1, BCR, RUFY1, SYNJ1, SNX17, PTX3, DOCK2]
GO:0035235;ionotropic glutamate receptor signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.310070521373587;27.195621953761602;6.558197802812269;9.102129923216596E-4;0.6863059058804069;[CLN3, CPEB4]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[ITGA2, TAOK2]
GO:0017148;negative regulation of translation;8.0;0.6493065804076676;0.6996532902038338;9.081980546124052;1114.6737408694362;4.99795013456894;0.03730712696566269;0.6305954023103058;[UPF1, BTG2, IGFBP5, YTHDF3, EIF4A3, EIF2AK3, CNOT10, FXR1, EIF4ENIF1, ILF3, XRN1, CNOT1, CAPRIN1, TPR, CNOT3, EIF4E2, CNOT8, CPEB4]
GO:0016973;poly(A)+ mRNA export from nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;122.0533615230405;7.004484905440688;0.004085016169282269;0.7734506956670166;[NXF3, PABPN1, POLDIP3, THOC2]
GO:0042987;amyloid precursor protein catabolic process;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;48.551292581453126;7.57984905034425;0.0016249680693747237;0.710754145523778;[CLN3]
GO:0006491;N-glycan processing;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;96.66964063832829;6.832634648514029;0.0032354458751365986;0.6725415662651573;[GNPTG, PRKCSH, EDEM1, MGAT4B, MAN1B1]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[SFRP1, TBL1XR1, USP34, NFKB1, ARNTL, DACT1]
GO:0006013;mannose metabolic process;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;34.676020684410545;7.474488534686424;0.0011605752059146955;0.7053660038532718;[PMM1, MAN2B2, MAN2B1]
GO:0045454;cell redox homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.944097044200298;5.572381008289503;0.0010691401802485107;0.5752128357670632;[EGLN2, TXNRD1, PRDX1]
GO:0043951;negative regulation of cAMP-mediated signaling;8.0;0.7866048967936545;0.7683024483968273;9.417215158824915;239.89301649848343;6.8867018697843045;0.008029003372506139;0.7271862538851576;[UBE2B, MGRN1]
GO:0038180;nerve growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;27.195621953761602;7.292166977892469;9.102129923216596E-4;0.7238411236270654;[CORO1A]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[RPL3, RNH1, NAB1, GFI1, GMNN, EIF4A3, ARID4A, CASC3, IKZF1, IKZF2, UBE2Z, YY1, EIF4ENIF1, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, DIP2A, ZNF564, TLE4, RPS9, IGFBP5, ZNF282, SLC35C2, SND1, RUNX2, ERN1, OLFM1, EID1, ILF3, SFRP1, BRMS1, ZNF93, XRN1, TBL1XR1, PSPC1, HOXB4, TIMELESS, ADNP, PPID, MAX, FOXG1, SUPT6H, GLG1, MTDH, FXR1, CCNB1, NLRP7, BAG3, TPR, HIVEP1, HESX1, SUDS3, A2M, BBS2, TFAP2A, DR1, CREBBP, UBE2I, XRCC5, NONO, H3F3A, EIF2AK3, CNOT10, LSM5, NFKB1, CDK9, CNOT4, CNOT6, PAN3, CDK5, CNOT1, PKIA, CAPRIN1, SP3, BCL3, CNOT3, ZNF658, NFE2L3, SKIV2L, CNOT8, DCP1A, EZH2, CPEB4, CDKN1C, USP36, HBS1L, CIITA, BTG2, CDKN1A, SMG1, OTUD7B, PTPN22, SMG5, FLCN, NIPBL, C1QBP, LRRFIP1, HIF1AN, CIC, DACT1, HAVCR2, UPF2, ZNF485, UPF1, TSC22D4, KLF12, PEG3, ARID1A, SIRT2, NCOR1, TFDP2, PTRH2, MTF2, LCOR, ETF1, EIF4E2, DCP2, HDAC3, ZNF350, HDAC1, NLRC4, LRP8, THBS1, RELA, ARNTL, PPP2CA, BCLAF1, RXRA, U2AF2, TP53INP1, POLR2G, EXOSC3, MTA2, E2F7, ZNF189, RPL19, E2F8, IRX1, RNF20, YTHDF3, NFYC, RPL23A, PER2, CENPF, GFI1B, HIST3H2A, NFIB, NFIC, TAF7, LIMS1]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[CCNF, KIF14, BUB1B, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, SEC13, RNF44, FBXO18, RAD23A, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, CCNB1, PSMB5, PSMB1, UBQLN1, RFFL, UBE2I, LRRC29, UBE2B, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, FBXL3, MAD2L1]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[SP3, ATPIF1, ACIN1, IKZF1, NFE2L1]
GO:0019430;removal of superoxide radicals;5.0;1.0;0.7902410118609202;9.628524252492122;35.16553377750127;7.212124270218933;0.00117695876860726;0.659069382437994;[CCS, PRDX1, ATP7A]
GO:0010501;RNA secondary structure unwinding;7.0;1.0;0.8509193652572005;9.628524252492122;115.0816327851482;5.948432231191374;0.0038516786825735262;0.6551224661907153;[DDX59, EIF4A3, DDX23, DDX42, DDX41]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[SMG1, MAST3, ROCK2, EIF2AK3, CDC7, VRK2, CLK1, ERN1, RPS6KA4, CCNB1, CDK5, CAMK4, STK38, MKNK2, STK38L, RIPK1, CAMK1, MARK2, CSNK1G2, CSNK1G1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[RNF20, STARD13, MCTP1, IGFBP5, IDH2, THBS1, BCR, NISCH, ABR, FLCN, SFRP1, RRAS, TBXA2R, ADORA3, TP53INP1, ARHGDIB, EPHA1, CLASP1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CD151, ONECUT2, ROCK2, DOCK8, ITGB3, CIB1, CD99L2, THBS1, CORO1A, NIPBL, C1QBP, CCL5, CTSH, NCKAP1L, CCL19, ATP7A, CLASP1, CCR2, SEMA6B, PDGFRB, MAP3K3, IGFBP5, CCL20, ITGA2, SPHK1, RAB11A, PTP4A1, VIL1, CREB3, IL6, KARS, SP1, IL23A, RUFY3, EPHA1, MAPRE1, TRIM32, HBEGF]
GO:0070309;lens fiber cell morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;47.452274261266446;8.16763571524637;0.0015881849152503491;0.7408135829017477;[TBC1D20]
GO:0090110;cargo loading into COPII-coated vesicle;7.0;1.0;0.8509193652572005;9.628524252492122;99.46684456500904;7.212124270218933;0.0033290657732425078;0.7197477358342742;[SEC13, TBC1D20, SEC24C]
GO:0048611;embryonic ectodermal digestive tract development;6.0;1.0;0.8231203125901445;9.628524252492122;33.60910941496887;9.777073627680469;0.0011248666458842863;0.8231203125901445;[VPS52]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[CDKN1C, ERRFI1, CDKN1A, CDKN2C, CIB1, PTPN22, DUSP14, PPP2CA, SFRP1, GNAQ, PKIA, NUP62, STK38, TAF7, CRIPAK, EPHA1, CHMP6]
GO:0000354;cis assembly of pre-catalytic spliceosome;7.0;1.0;0.8509193652572005;9.628524252492122;66.59596265062147;9.083926447120524;0.002228906937441061;0.8154717862087246;[DDX23]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[CIITA, BTG2, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, C1QBP, SAP130, WWC3, EP300, SOX8, LRRFIP1, HIF1AN, CIC, ZNF564, DACT1, TLE4, KLF12, PEG3, ARID1A, SIRT2, EID1, BRMS1, NCOR1, TBL1XR1, MTF2, HOXB4, TIMELESS, LCOR, PPID, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RELA, MTDH, RXRA, BAG3, TPR, HIVEP1, HESX1, SUDS3, MTA2, E2F7, ZNF189, E2F8, IRX1, TFAP2A, DR1, CREBBP, UBE2I, NFKB1, PER2, GFI1B, CNOT1, NFIB, NFIC, PKIA, SP3, NFE2L3, TAF7, EZH2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[POLB, ACTR2, SETDB1, TBXA2R, TP53INP1, ITPR2, SDF4]
GO:0010836;negative regulation of protein ADP-ribosylation;9.0;1.0;0.896240625180289;9.628524252492122;445.796546324131;8.67846133901236;0.014920409214624487;0.8400575416471059;[PNKP]
GO:0016139;glycoside catabolic process;6.0;0.7140352122741334;0.6801379187272112;8.712233520617966;75.12934532068766;7.474488534686424;0.0025145115758623713;0.7053660038532718;[GUSB, GBA2]
GO:0033030;negative regulation of neutrophil apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.083926447120524;0.010085298248760914;0.8607930461318132;[ITPKB]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[DDB1, WDR48, UBE2B, PNKP]
GO:0044829;positive regulation by host of viral genome replication;9.0;1.0;0.896240625180289;9.628524252492122;209.9603317012029;7.8311634786251565;0.0070271833500085345;0.7967266896635242;[TBC1D20]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, SAP130, ZXDC, DPF2, TRIM24, SOX8, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, RAD21, HLTF, HIVEP1, HESX1, HIVEP2, ZNF264, SETDB1, ZNF260, XRCC5, INTS3, PBX3, FLI1, SOX30, STAG1, ZNF30, INTS4, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, INTS10, ATF7IP2, HOXC13, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, ZNF485, TSC22D4, COMMD3, BAZ1A, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR1, TFEC, MED20, VGLL4, ZNF350, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, GPBP1L1, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIB, NFIC, MARS, ZNF696, CRTC2, NAB1, ARID4A, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, TRAPPC2, TFAP2A, ZBTB17, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZNF658, NFE2L3, CNOT8, TMEM18, ZNF532, ZNF410, NFE2L1, CIITA, ONECUT2, CHD1, AFF4, LBH, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, LRRFIP1, HIF1AN, KLF12, TBP, KLF13, BUD31, MKL1, ARNT, SAFB, ARID1A, CREB3, ZNF519, TFDP2, ELF4, LCOR, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3C, TNIP2, POLR3E, TAF7, MNDA]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[EYA2, SSU72, DUSP28, PTPN22, PPP2R5D, SSH3, CDC25A, PPM1G, DUSP14, PPP1CB, PTP4A1, PPP2CA, PPP1CC, DUSP23, PPP6C, PTPRA, CTDSP2]
GO:0033273;response to vitamin;6.0;0.6664901433067099;0.6563653842434994;8.438940185618286;22.816494584803845;5.311165509025885;7.636475402414068E-4;0.5947335637161829;[BECN1, CD4, SFRP1, SETDB1, ITGA2, RELA]
GO:0043970;histone H3-K9 acetylation;13.0;1.0;0.9625549647676366;9.628524252492122;849.3943267986753;9.083926447120524;0.028428463712686935;0.9271073857191605;[CRTC2]
GO:0051480;regulation of cytosolic calcium ion concentration;10.0;0.6634067003016617;0.7469443620117512;9.01761517016915;288.6919123283276;4.053488525728088;0.009662258499776054;0.6225366035731486;[OXTR, GPR55, ITPR2, CLN3, CD4, GNAT2, TBXA2R, PDE6B, CALM3, CCL19, CALM1, CALM2, KCNK3, NTSR1, GTF2I, CCR2]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[MAML1, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, TIAL1, RPS6KA4, SAP130, ZXDC, DPF2, TRIM24, SOX8, FBXO5, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, FLT3LG, SND1, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, KARS, IL23A, EWSR1, RFX4, BOLA3, HOXB4, TRIM14, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, ZNF25, MTDH, RAD21, HLTF, HIVEP1, HESX1, SCAP, HIVEP2, ZNF264, CREBBP, SETDB1, ZNF260, XRCC5, H3F3A, PBX3, EIF2AK3, ERLIN2, FLI1, SOX30, SETX, STAG1, GOLGB1, PKIA, ZNF30, EZH2, CDKN1C, SETD5, AHCTF1, BTG2, CDKN1A, SETD3, ELL, ATF7IP2, OTUD7B, HOXC13, ZNF45, AATF, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, HAVCR2, ZNF485, TSC22D4, SEC13, NCOA6, SPHK1, COMMD3, BAZ1A, TMEM173, PPRC1, ZFX, MED29, SIRT2, VAV1, MED28, TOX4, GAL, NCOR1, MTF2, TFEC, MED20, VGLL4, ARHGEF5, ZNF350, NEDD8, TRAK1, ZNF69, RELA, ARNTL, PPP2CA, SERTAD3, BCLAF1, RXRA, SERTAD2, UBN1, GPBP1L1, SCAND1, ZNF462, EGLN2, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ITCH, NLRP12, CENPF, GFI1B, HIST3H2A, NFIB, NFIC, CAMK4, MARS, PSMC1, CAMK1, ZNF696, LIMS1, CRTC2, NCF1, NAB1, CD80, GMNN, ARID4A, CIB1, RORA, YY1, ADORA3, WWC3, ZNF207, EP300, SNIP1, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, SSU72, PIAS2, ERN1, ARMCX3, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, GTF2E2, STK3, BAG3, TPR, ZNF549, ZNF548, DVL3, NLRP3, RIPK1, SUDS3, ZNF544, TRAPPC2, TFAP2A, ZBTB17, DR1, UBE2I, NONO, CNOT10, NFKB1, CDK9, NFKBIA, CNOT6, IRAK1BP1, IL6, TFCP2, COPS5, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZNF658, NFE2L3, CNOT8, ZNF532, ZNF410, NFE2L1, USP36, CIITA, ONECUT2, ITGB2, DDX41, CHD1, AFF4, FLCN, LBH, ZNF407, NUP62, GATAD1, ZNF768, ZNF525, ZNF524, LRRFIP1, HIF1AN, DACT1, KLF12, TBP, KLF13, PEG3, DTX3L, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, CREB3, ZNF519, TFDP2, SETBP1, ELF4, LCOR, ZNF630, ITGB3BP, GTF3C1, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, NLRC4, LRP8, TFPT, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, ASCC3, ZNF622, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, RNF20, CHURC1, EYA2, FBXL15, ARID3B, DEK, USF2, CD4, POLR3C, TNIP2, TAF7, MNDA, KRAS, TRIM32]
GO:0007205;protein kinase C-activating G-protein coupled receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;6.444869117505266;9.028936615729279E-4;0.6527112189764278;[DGKD, DGKA]
GO:0006359;regulation of transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.52844079393514;248.56913769389934;6.481236761676141;0.008319385340914571;0.7466917612613706;[GTF3C1, TBP, ELL, POLR3C]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[MAML1, CCNH, GFI1, IKZF1, IKZF2, ELK1, TIAL1, RPS6KA4, SAP130, ZXDC, DPF2, SOX8, IER5, IER2, ZNF282, FLT3LG, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, IL23A, RFX4, BOLA3, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, ZNF25, MTDH, RAD21, HLTF, HIVEP1, HESX1, SCAP, HIVEP2, ZNF264, CREBBP, ZNF260, PBX3, ERLIN2, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, EZH2, AHCTF1, BTG2, CDKN1A, SETD3, ELL, OTUD7B, HOXC13, ZNF45, AATF, NIPBL, ZMYM2, C1QBP, CIC, HAVCR2, ZNF485, TSC22D4, NCOA6, TMEM173, PPRC1, ZFX, SIRT2, TOX4, GAL, NCOR1, MTF2, TFEC, MED20, ZNF350, NEDD8, TRAK1, ZNF69, RELA, ARNTL, RXRA, UBN1, ZNF462, EGLN2, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIB, NFIC, PSMC1, CAMK1, ZNF696, CRTC2, ARID4A, RORA, YY1, WWC3, EP300, ZNF564, GTF2I, TLE4, ZNF441, SSU72, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BAG3, TPR, ZNF549, ZNF548, NLRP3, RIPK1, SUDS3, ZNF544, TFAP2A, ZBTB17, DR1, UBE2I, NONO, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, ZNF658, NFE2L3, ZNF532, ZNF410, NFE2L1, CIITA, ONECUT2, DDX41, CHD1, FLCN, ZNF407, GATAD1, ZNF768, ZNF525, ZNF524, LRRFIP1, HIF1AN, DACT1, KLF12, TBP, KLF13, PEG3, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, CREB3, ZNF519, TFDP2, SETBP1, ELF4, LCOR, SMARCD2, HDAC3, HDAC1, WBP2, LRP8, ZNF622, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, FBXL15, ARID3B, DEK, USF2, TNIP2, TAF7]
GO:0001575;globoside metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.567899630675686;149.5390603186064;9.083926447120524;0.00500493777244691;0.839552420951524;[CLN3]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[FLT3LG, VPS54, KRAS, CORO1A, CCR2]
GO:0051353;positive regulation of oxidoreductase activity;5.0;0.6873818243518346;0.6339319240368375;8.560683622490766;68.71016387165909;5.905872616772578;0.002299667349651622;0.5922676121338333;[CCS, KRAS, ATP7A]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[ERN1, NCF1, TAOK2, DVL3, RIPK1, ZNF622, CCL19, MAPK8IP3, ARHGEF5, STK3]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AVEN, BTG2, CDKN1A, DOCK8, KIF14, CIB1, AATF, UBE2Z, NUP62, CFL1, CASP2, CTSH, SOX8, PDGFRB, TSC22D4, FGA, DFFA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, DDB1, ITPKB, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, PPID, BECN1, HDAC3, HDAC1, NLRC4, THBS1, CORO1A, RELA, MTDH, CLN3, BAG3, CCL5, LMNA, NCKAP1L, RIPK1, CCL19, RFFL, SNCB, BID, NTSR1, TBX1, TFAP2A, PRELID1, UBE2B, EYA2, NONO, SYVN1, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, ITCH, IL6, SON, COPS5, TNIP2, BCL3, KRAS, ERCC5, PDCD1, TRIM32, MAD2L1, CPEB4]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[HRK, UBE2Z, BBC3, FLCN, AKAP13, RPS6KA2, C1QBP, ARL6IP5, CASP2, CTSH, CTLA4, RBM5, PDGFRB, DFFA, FBXO18, ATPIF1, PLAUR, YWHAZ, SIRT2, VAV1, SFRP1, GAL, BRMS1, TFDP2, PTRH2, ARHGEF1, ARHGEF5, ITGB3BP, PPID, DIABLO, NLRC4, THBS1, STK3, ABR, BCLAF1, CCL5, UBD, TP53INP1, TP53BP2, NLRP3, RIPK1, SUDS3, ZNF622, ECT2, BID, NTSR1, TFAP2A, PRELID1, EIF2AK3, G0S2, TNFRSF10A, HSPE1, NLRP12, IL6, FAP, CDK5, MNDA, PDCD1, SERINC3]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[ITGB3, CDC7, CORO1A, TM9SF4, UNC13D]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[BECN1, NCF1, TXNRD1, GPX7, VRK2, SIRT2, RELA, SETX, IL6, CCS, PRDX1, TP53INP1, PXMP2, ECT2, NFE2L1, EZH2]
GO:0033147;negative regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;234.23542340630428;7.138016298065211;0.007839648823214116;0.7400384854347593;[LBH, CNOT1, CRIPAK]
GO:0030433;ubiquitin-dependent ERAD pathway;10.0;0.9326813400603323;0.8815816818910864;9.600353375525426;603.0491029665483;5.557565922504363;0.02018351076733335;0.6994551915910392;[SEC13, RNF103, NPLOC4, EDEM1, PSMC1, DERL3, SYVN1, UBQLN1, DERL2, MAN1B1, ERLIN2]
